- Home
- EDSA vs MGIH Comparison
EDSA vs MGIH Comparison
Compare EDSA & MGIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- MGIH
- Stock Information
- Founded
- EDSA 2015
- MGIH 1978
- Country
- EDSA Canada
- MGIH Hong Kong
- Employees
- EDSA N/A
- MGIH N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- MGIH Publishing
- Sector
- EDSA Health Care
- MGIH Consumer Discretionary
- Exchange
- EDSA Nasdaq
- MGIH Nasdaq
- Market Cap
- EDSA 14.6M
- MGIH 18.7M
- IPO Year
- EDSA N/A
- MGIH 2023
- Fundamental
- Price
- EDSA $4.36
- MGIH $1.58
- Analyst Decision
- EDSA Strong Buy
- MGIH
- Analyst Count
- EDSA 2
- MGIH 0
- Target Price
- EDSA $39.00
- MGIH N/A
- AVG Volume (30 Days)
- EDSA 5.3K
- MGIH 36.2K
- Earning Date
- EDSA 08-09-2024
- MGIH 10-30-2024
- Dividend Yield
- EDSA N/A
- MGIH N/A
- EPS Growth
- EDSA N/A
- MGIH N/A
- EPS
- EDSA N/A
- MGIH N/A
- Revenue
- EDSA N/A
- MGIH $43,080,647.00
- Revenue This Year
- EDSA N/A
- MGIH N/A
- Revenue Next Year
- EDSA N/A
- MGIH N/A
- P/E Ratio
- EDSA N/A
- MGIH N/A
- Revenue Growth
- EDSA N/A
- MGIH N/A
- 52 Week Low
- EDSA $2.46
- MGIH $0.89
- 52 Week High
- EDSA $8.33
- MGIH $9.57
- Technical
- Relative Strength Index (RSI)
- EDSA 44.80
- MGIH 49.53
- Support Level
- EDSA $4.20
- MGIH $1.57
- Resistance Level
- EDSA $4.80
- MGIH $1.69
- Average True Range (ATR)
- EDSA 0.24
- MGIH 0.12
- MACD
- EDSA -0.01
- MGIH -0.01
- Stochastic Oscillator
- EDSA 29.03
- MGIH 22.92
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
About MGIH Millennium Group International Holdings Limited
Millennium Group International Holdings Ltd is a paper-based packaging solutions supplier. It offers paper-based inner and outer packaging products which can be broadly categorized into packaging products and corrugated products.